Combination therapy with SSRIs and 5-HT1A agonists and partial agonists, such as buspirone, has been shown to ameliorate SSRI-induced sexual dysfunction (Clayton and Montejo 2006; Landen et al. 1999). Here, HTR1A is linked to sexual dysfunction.